Browsing by Keyword : Antineoplastic Agents/adverse effects
Showing results 1 to 9 of 9
| Pub Year | | Title | Author(s) |
| 2017 | | Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer | 강석윤, 김지훈, 노오규, 박래웅, 오영택, 윤덕용, 이현우, 전미선 |
| 2017 | | Altered intrinsic brain activity after chemotherapy in patients with gastric cancer: A preliminary study | 김현지 |
| 2009 | | Cathepsin D and eukaryotic translation elongation factor 1 as promising markers of cellular senescence. | 윤계순 |
| 2008 | | Change of platelet activation markers using flow cytometry in patients with hematology/oncology disorders after transfusion. | 박준성, 이위교, 임영애, 조성란 |
| 2009 | | Chemotherapy-related amenorrhea in premenopausal women with breast cancer. | - |
| 2015 | | Clinical predictors associated with proton pump inhibitor-induced hypomagnesemia. | 강대용 |
| 2017 | | Feasibility and Efficacy of Eribulin Mesilate in Korean Patients with Metastatic Breast Cancer: Korean Multi-center Phase IV Clinical Study Results | 강석윤 |
| 2016 | | Imatinib withdrawal syndrome and longer duration of imatinib have a close association with a lower molecular relapse after treatment discontinuation: the KID study | 박준성 |
| 2014 | | Novel synthetic protective compound, KR-22335, against cisplatin-induced auditory cell death. | 강성운, 김철호, 신유섭 |
1
